α1-adrenergic, D1, and D2 receptors interactions in the prefrontal cortex: Implications for the modality of action of different types of neuroleptics

Synapse

Volumn 30, Issue 4, 1998, Pages 362-370

  Gioanni, Yves ^a   Thierry, Anne Marie ^a   Glowinski, Jacques ^a   Tassin, Jean Pol ^a  

^a INSERM   (France)

Author keywords

1 adrenergic; D1, D2; Neuroleptics; Prefrontal cortex; Rat; Receptors; Ventral tegmental area

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; CLOZAPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NEUROLEPTIC AGENT; PRAZOSIN; SULPIRIDE; ALPHA ADRENERGIC RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IONTOPHORESIS; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BLOCKING; VENTRAL TEGMENTUM; ANIMAL; BRAIN CORTEX; DRUG ANTAGONISM; DRUG EFFECT; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL INHIBITION; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIPSYCHOTIC AGENTS; CEREBRAL CORTEX; CLOZAPINE; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HALOPERIDOL; INJECTIONS, INTRAVENOUS; IONTOPHORESIS; NEURAL INHIBITION; PRAZOSIN; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SULPIRIDE;

EID: 0031593976     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199812)30:4<362::AID-SYN3>3.0.CO;2-W     Document Type: Article

References (38)

1. Arnsten, A.F., and Jentsch, J.D. (1997) The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys. Pharmacol. Biochem. Behav., 58:55-59.
2. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur. J. Neurosc., 6:293-298.
3. 3H]acetylcholine in striatal compartments of the rat: Regulatory roles of dopamine and GABA. Neuroscience, 81:113-127.
4. Claghorn, J., Honigfeld, G., Abuzzahab, F.S. Sr, Wang, R., Steinbook, R., Tuason, V., and Klerman, G. (1987) The risks and benefits of clozapine versus chlorpromazine. J. Clin. Psychopharmacol., 7:377-384.
5. Ferron, A., Thierry, A.M., Le Douarin, C., and Glowinski, J. (1984) Inhibitory influence of the mesocortical DA system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex. Brain Res., 302:257-265.
6. Gaspar, P., Berger, B., Febvret, A., Vigny, A., and Henry, J.P. (1989) Catecholaminergic innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J. Comp. Neurol., 279:249-271.
7. Gaspar, P., Bloch, B., and Le Moine, C. (1995) D1 and D2 receptor gene expression in the rat frontal cortex: Cellular localization in different classes of efferent neurons. Eur. J. Neurosc., 7:1050-1063.
8. Godbout, R., Mantz, J., Pirot, S., Glowinski, J., and Thierry, A.M. (1991) Inhibitory influence of the mesocortical DA neurons on their target cells: Electrophysiological and pharmacological characterization. J. Pharmacol. Exp. Ther., 258:728-738.
9. Grabowska-Anden, and Anden, N.E. (1987) Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats. J. Pharm. Pharmacol., 39:660-661.
10. 1-adrenoceptor recognition sites by urapidil derivates and other selective antagonists. Br. J. Pharmacol., 97:691-700.
11. Hyttel, J., Larsen, J.J., Christensen, A.V., and Arnt, J. (1985) Receptor-binding profiles of neuroleptics. In: Dyskinesia: Research and Treatment. D.E. Casey, T.N. Chase, A.V. Christensen, and J. Gerlach, eds. Springer-Verlag, New York, pp. 9-18.
12. Kane, J., Honigfeld, G., Singer, J., and Meltzer, H. (1988) Clozapine for treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry, 45:789-796.
13. Lindvall, O., and Björklund, A. (1984) General organization of cortical monoamine systems. In: Monoamine Innervation of Cerebral Cortex. L. Descarries, T.R. Reader, and H.H. Jasper, eds. Liss, New York, pp. 9-40.
14. Mantz, J., Godbout, R., Tassin, J.P., Glowinski, J., and Thierry, A.M. (1990) Inhibition of spontaneous and evoked unit activity in the rat medial prefrontal cortex by mesencephalic raphe nuclei. Brain Res., 524:22-30.
15. 1A-subtype in rat submaxillary gland. Br. J. Pharmacol., 98:883-889.
16. Meltzer, H.Y. (1989) Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl.), 99:S18-S27.
17. Meltzer, H.Y., and Stahl, S.M. (1976) The dopamine hypothesis of schizophrenia: A review. Schizophr. Bull., 2:19-76.
18. Meltzer, H.Y., Matsubara, S., and Lee, J.C. (1989) The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol. Bull., 25:390-392.
19. Murray, A.M., and Waddington, J.L. (1989a) Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behavior: Studies with the new enantioselective D-2 agonist LY 163502. Psychopharmcology 98:245-250.
20. Murray, A.M., and Waddington, J.L. (1989b) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: Two directions of D-1:D-2 interaction. Eur. J. Pharmacol., 160:377-384.
21. Nordstrom, A.L., Farde, L., Nyberg, S., Karlsson, P., Halldin, C., and Sedvall, G. (1995) D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients. Am. J. Psychiatry, 152:1444-1449.
22. Paxinos, G., and Watson, C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
23. Rosengarten, H., Schweitzer, J.W., and Friedhoff, A.J. (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci. 39:29-35.
24. Sawaguchi, T., and Goldman-Rakic, P.S. (1991) D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science, 251:947-950.
25. Seeman, P., and Grigoriadis, D. (1987) Dopamine receptors in brain and periphery. Neurochem. Int., 10:1-25.
26. Sorensen, S.M., Kehne, J.H., Fadayel, G.M., Humphreys, T.M., Ketteler, H.J., Sullivan, C.K., Taylor, V.L., and Schmidt, C.J. (1993) Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: Behavioural, electrophysiological and neurochemical studies. J. Pharmacol. Exp. Ther., 256:684-691.
27. Sumiyoshi, T., Kido, H., Sakamoto, H., Urasaki, K., Yamaguchi, N., Mori, H., and Shiba, K. (1994) Time course of dopamine 1, 2 and serotonin2 receptor binding of antipsychotics in vivo. Pharmacol. Biochem. Behav., 49:165-169.
28. Tassin, J.P., Trovero, F., Vezina, P., Blanc, G., Glowinski, J., and Hervé, D. (1995) L'hétéro-régulation des récepteurs ou la présence d'une relation fonctionnelle entre deux ensembles neuronaux. Med. Sci., 11:829-836.
29. Thierry, A.M., Blanc, G., Sobel, A., Stinus, L., and Glowinski, J. (1973) Dopaminergic terminals in the rat cortex. Science, 183:499-501.
30. Thierry, A.M., Le Douarin, C., Penit, J., Ferron, A., and Glowinski, J. (1986) Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex. Brain Res. Bull., 16:155-160.
31. 1-adrenergic receptors. J. Neurochem., 59:331-337.
32. 1adrenergic and N-methyl-D-aspartate receptors. J. Neurosci., 14:6280-6288.
33. Vezina, P., Blanc, G., Glowinski, J., and Tassin, J.P. (1991) Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: A role for the cortical D-1 dopamine receptor. Eur. J. Neurosc., 3:1001-1007.
34. Wachtel, S.R., and White, F.J. (1995) The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons. Neurosci. Lett., 199:13-16.
35. Wachtel, S.R., Brooderson, R.J., and White F.J. (1992) Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38893 in the rat. Psychopharmacology, 109:41-48.
36. Waddington, J.L., Molloy, A.G., O'Boyle, K.M., and Mashurano, M. (1986) Motor consequences of D-1 dopamine receptor stimulation and blockade. Clin. Neuropharmacol., 9(Suppl.)4:20-22.
37. Weinberger, D.R., Berman, K.F., Suddath, R., and Torrey, E.F. (1992) Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional cerebral blood flow study of discordant monozigotic twins. Am. J. Psychiatry, 149:890-897.
38. 2 Dopamine Receptor Interactions. Neuroscience and Psychopharmacology. J. Waddington, ed. Academic Press, London, pp. 79-114.